Loading...
Zirconium oxide nanoparticles in advancing photodynamic therapy for cancer treatment
Citations
Altmetric:
Video URL
Date
2026-01-31
Collections
Abstract
This review delves into the intricacies of Photodynamic Therapy (PDT), focusing on mechanisms such as the accumulation of selective photosensitizers and the generation of Reactive Oxygen Species (ROS). Research is investigating the use of zirconium oxide nanoparticles (ZrO2 NPs) and their combination with upconversion nanoparticles. The functionalization of ZrO2 NPs is stressed for targeted drug administration and enhanced therapeutic effects. Addressing PDT challenges, ZrO2 NPs exhibit potential to enhance treatment accuracy, minimize side effects, and improve overall success. Supported by preclinical and clinical research, zirconium-based PDT emerges as a transformative cancer therapy technique. Integrating ZrO2 NPs into PDT represents a groundbreaking approach, allowing selective cancer cell targeting and promising improved treatment outcomes and synergies with other modalities. With demonstrated safety and efficacy, ZrO2 PDT constitutes a vital component in advancing cancer patient outcomes globally.